Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia by Rahman, Sunniyat, Magnussen, Michael, León, Theresa E., Farah, Nadine, Li, Zhaodong, Alapi, Krisztina Z., Mitchell, Rachel J., Naughton, Tom, Fielding, Adele K., Pizzey, Arnold, Bustraan, Sophia, Popa, Teodora, Pike-Overzet, Karin, Garcia-Perez, Laura, Gale, Rosemary E., Linch, David C., Staal, Frank J. T., Look, A. Thomas, Mansour, Marc R., Abraham, Brian Joseph, Allen, Christopher D, Young, Richard A.

“…American Society of Hematology…”
Get full text
Get full text
Get full text

Enhanced phosphocholine metabolism is essential for terminal erythropoiesis by Huang, Nai-Jia, Lin, Chung-Yueh, Pishesha, Novalia, Lewis, Caroline A., Freinkman, Elizaveta, Lodish, Harvey

“…American Society of Hematology…”
Get full text

Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development by Woo, Andrew J., Patry, Chelsea-Ann A., Ghamari, Alireza, Pregernig, Gabriela, Yuan, Daniel, Zheng, Kangni, Piers, Taylor, Hibbs, Moira, Li, Ji, Fidalgo, Miguel, Wang, Jenny Y., Lee, Joo-Hyeon, Leedman, Peter J., Wang, Jianlong, Fraenkel, Ernest, Cantor, Alan B.

“…American Society of Hematology…”
Get full text

A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth by Young, Richard

“…American Society of Hematology…”
Get full text

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS by Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M

“…American Society of Hematology…”

Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs by Iskander, D, Psaila, B, Gerrard, G, Chaidos, A, Foong, HE, Harrington, Y, Karnik, LC, Roberts, I, de la Fuente, J, Karadimitris, A

“…American Society of Hematology…”

Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression by Silveira, DRA, Chatzikyriakou, P, Yavorska, O, Mackie, S, Hulks, R, Siejka-Zielinska, P, Corby, A, Smith, A, Brown, B, Metzner, M, Milne, TA, Penard-Lacronique, V, Song, C, Hasan, M, Thakurta, A, Vyas, P, Kriaucionis, S, Quek, L

“…American Society of Hematology…”

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up by Salisbury, R, Iotchkova, V, Jaafar, S, Morton, J, Sangha, G, Untiveros, P, Curry, N, Shapiro, S

“…American Society of Hematology…”

A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acut... by Vyas, P, Daver, N, Chao, M, Xing, G, Renard, C, Ramsingh, G, Wei, AH, Sallman, DA

“…American Society of Hematology…”

Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for... by Ward, C, Read, M, Seymour, L

“…American Society of Hematology…”

Expression of the human alpha-globin cluster in the absence of the major regulatory element Mcs-R2 by Badat, M, Davies, JOJ, Van Beers, EJ, Harteveld, C, Downes, D, Higgs, DR

“…American Society of Hematology…”

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO

“…American Society of Hematology…”

Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis by Lecomte, S, Devreux, J, de Streel, G, van Baren, N, Havelange, V, Schröder, D, Vaherto, N, Vanhaver, C, Vanderaa, C, Dupuis, N, Pecquet, C, Coulie, PG, Constantinescu, SN, Lucas, S

“…American Society of Hematology…”

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia by Stein, EM, DiNardo, CD, Pollyea, DA, Fathi, AT, Roboz, GJ, Altman, JK, Stone, RM, DeAngelo, DJ, Levine, RL, Flinn, IW, Kantarjian, HM, Collins, R, Patel, MR, Frankel, AE, Stein, A, Sekeres, MA, Swords, RT, Medeiros, BC, Willekens, C, Vyas, P, Tosolini, A, Xu, Q, Knight, RD, Yen, KE, Agresta, S, De Botton, S, Tallman, MS

“…American Society of Hematology…”

A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice by Jain, R, Sheridan, J, Policheni, A, Heinlein, M, Gandolfo, L, Dewson, G, Smyth, G, Sansom, S, Fu, N, Visvander, J, Hollander, G, Strasser, A, Gray, D

“…American Society of Hematology…”

Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function by Liu, Y, Kretz, CA, Maeder, ML, Richter, CE, Tsao, P, Vo, AH, Huarng, MC, Rode, T, Hu, Z, Mehra, R, Olson, ST, Joung, JK, Shavit, JA

“…American Society of Hematology…”

Degrading JAK2 in ALL by ruxolitinib-based PROTACs by Constantinescu, SN, Pecquet, C

“…American Society of Hematology…”

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the ra... by DiNardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Bluemmert, I, Yu, X, Hasan, M, Martin-Regueira, P, de Botton, S

“…American Society of Hematology…”

Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Le... by Craddock, C, Versluis, J, Labopin, M, Socie, G, Huyn, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Markus, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, JR, Schmid, C, Ossenkoppele, GJ, Vyas, P, Löwenberg, B, Mohty, M, Cornelissen, JJ, Nagler, A

“…American Society of Hematology…”

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome by Cruz Hernandez, D, Metzner, M, de Groot, AP, Usukhbayar, B, Elliott, N, Roberts, I, Vyas, P

“…American Society of Hematology…”